BioPlus Acquisition Corp.

Q: Jun 30 2023

Q: Mar 31 2023

FY: Dec 31 2022

Q: Sep 30 2022

Q: Jun 30 2022

Q: Mar 31 2022

FY: Dec 31 2021

1.01,1.02,8.01,9.01

7.01,9.01

1.01,2.03,3.02,5.03,5.07,9.01

7.01,9.01

1.01,7.01,9.01

8.01

8.01,9.01

Entry into a Material Definitive Agreement

Certification of termination of registration of a class of securities (Section 12(g))

Notification of removal from listing and/or registration on a national securities exchange

Withdrawal of a registration statement

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Registration statement under Securities Act of 1933 (amendment)

Written communication about a business combination transaction (Rule 425)

Registration statement under Securities Act of 1933 (amendment)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Registration statement under Securities Act of 1933

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Prospectus Supplement with Pricing Information

Notice of Effectiveness

No description available

Certification of approval for listing and registration on a national securities exchange

Registration of Securities on Exchange

Definitive Proxy Statement

Preliminary Proxy Statement

none

none

none

none

none

VIEUX ALEX SERGE

none

none

none

none

none

Saba Capital Management, L.P.

none

none

none

none

none

VIEUX ALEX SERGE

RIGBY JONATHAN

Cross Shawn

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Draft registration statement (confidential submission)